Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia

The clinical course of the new coronavirus disease 2019 (COVID-19) has shown that patients with chronic lymphocytic leukemia (CLL) are characterized by a high mortality rate, poor response to standard treatment, and low virus-specific antibody response after recovery and/or vaccination. To date, the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of molecular sciences 2022-12, Vol.24 (1), p.416
Hauptverfasser:	Komissarov, Alexey A, Kislova, Maria, Molodtsov, Ivan A, Petrenko, Andrei A, Dmitrieva, Elena, Okuneva, Maria, Peshkova, Iuliia O, Shakirova, Naina T, Potashnikova, Daria M, Tvorogova, Anna V, Ptushkin, Vadim V, Efimov, Grigory A, Nikitin, Eugene A, Vasilieva, Elena
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Viral COVID-19 - prevention & control COVID-19 Vaccines - immunology Humans Leukemia, Lymphocytic, Chronic, B-Cell T-Lymphocytes Vaccination Vaccines, Combined Vaccines, Synthetic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!